Catalyst Pharmaceuticals (CPRX) EBITDA (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) reported EBITDA of $83.01 million for Q1 2026, up 14.0% from $72.83 million a year earlier and up 16.3% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) EBITDA (2010 - 2026) Analysis & Trends
Over the twelve months ended Mar 31, 2026, Catalyst Pharmaceuticals' EBITDA came in at $305.83 million, up 13.6% year-over-year; for FY2025, it was $295.65 million, up 26.9% from FY2024.
- EBITDA has increased for six consecutive years, with a five-year compound annual growth rate of 48.2% (FY2020 to FY2025).
- By year, EBITDA came in at $232.9 million in FY2024 (+94.6%), $119.69 million in FY2023 (+16.1%), $103.08 million in FY2022 (+96.0%) and $52.58 million in FY2021 (+27.0%).
- The Q1 2026 figure ranks as the highest quarterly EBITDA in data going back to Q3 2010.
- Year over year, EBITDA gained in six of the last seven quarters, with growth averaging 30.5%.
- The high point for year-over-year EBITDA in five years was Q4 2022 (growth of 145.9%); the low point was Q1 2024 (a decline of 13.4%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $71.38 million (Q4 2025), $75.68 million (Q3 2025) and $75.76 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 83.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 83.01 Mn |
| Dec 31, 2025 | 71.38 Mn |
| Sep 30, 2025 | 75.68 Mn |
| Jun 30, 2025 | 75.76 Mn |
| Mar 31, 2025 | 72.83 Mn |
| Dec 31, 2024 | 72.30 Mn |
| Sep 30, 2024 | 60.36 Mn |
| Jun 30, 2024 | 63.68 Mn |
| Mar 31, 2024 | 36.56 Mn |
| Dec 31, 2023 | 50.84 Mn |
| Sep 30, 2023 | -28.62 Mn |
| Jun 30, 2023 | 55.27 Mn |
| Mar 31, 2023 | 42.21 Mn |
| Dec 31, 2022 | 31.42 Mn |
| Sep 30, 2022 | 25.14 Mn |
| Jun 30, 2022 | 28.61 Mn |
| Mar 31, 2022 | 17.40 Mn |
| Dec 31, 2021 | 12.78 Mn |
| Sep 30, 2021 | 14.04 Mn |
| Jun 30, 2021 | 15.87 Mn |
API Access
Catalyst Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();